These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25685282)

  • 1. β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.
    Saisho Y
    World J Diabetes; 2015 Feb; 6(1):109-24. PubMed ID: 25685282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Beta Cell Function for the Treatment of Type 2 Diabetes.
    Saisho Y
    J Clin Med; 2014 Aug; 3(3):923-43. PubMed ID: 26237486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes.
    Inaishi J; Saisho Y
    J Clin Med; 2017 Nov; 6(12):. PubMed ID: 29483484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review.
    Inaishi J; Saisho Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):121-127. PubMed ID: 30173655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Regulators of Human β-cell Mass to Achieve β-cell-centric Approach Toward Type 2 Diabetes.
    Sasaki H; Saisho Y; Inaishi J; Itoh H
    J Endocr Soc; 2021 Oct; 5(10):bvab128. PubMed ID: 34405128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell failure in type 2 diabetes mellitus.
    Lencioni C; Lupi R; Del Prato S
    Curr Diab Rep; 2008 Jun; 8(3):179-84. PubMed ID: 18625113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic fat content is associated with β-cell function and insulin resistance in Chinese type 2 diabetes subjects.
    Lu T; Wang Y; Dou T; Xue B; Tan Y; Yang J
    Endocr J; 2019 Mar; 66(3):265-270. PubMed ID: 30700664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the molecular genetics of type 2 diabetes mellitus.
    Brunetti A; Chiefari E; Foti D
    World J Diabetes; 2014 Apr; 5(2):128-40. PubMed ID: 24748926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of exercise on insulin sensitivity and beta-cell function: is exercise sufficient for the prevention of youth-onset type 2 diabetes?
    Kim JY; Jeon JY
    Ann Pediatr Endocrinol Metab; 2020 Dec; 25(4):208-216. PubMed ID: 33401879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserving insulin secretion in Type 2 diabetes mellitus.
    Tibaldi J
    Expert Rev Endocrinol Metab; 2008 Mar; 3(2):147-159. PubMed ID: 30764089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide.
    Schwartz S
    Curr Med Res Opin; 2008 Nov; 24(11):3009-22. PubMed ID: 18828960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies.
    Al-Mrabeh A
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33672162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
    Li FP; Zhang SQ; Wang F; Huang YQ; Fu ZZ; Yan L
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):940-3. PubMed ID: 20079327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the pharmacotherapy options for treating prediabetes?
    Daniele G; Abdul-Ghani M; DeFronzo RA
    Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes.
    Mudaliar S
    Int J Clin Pract; 2013 Sep; 67(9):876-87. PubMed ID: 23952467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of obestatin in roux-en-Y gastric bypass-induced remission of type 2 diabetes mellitus.
    Wang JL; Xu XH; Zhang XJ; Li WH
    Diabetes Metab Res Rev; 2016 Sep; 32(6):470-7. PubMed ID: 26445403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.